SG11202112544XA - Methods and reagents for diagnosis of sars-cov-2 infection - Google Patents
Methods and reagents for diagnosis of sars-cov-2 infectionInfo
- Publication number
- SG11202112544XA SG11202112544XA SG11202112544XA SG11202112544XA SG11202112544XA SG 11202112544X A SG11202112544X A SG 11202112544XA SG 11202112544X A SG11202112544X A SG 11202112544XA SG 11202112544X A SG11202112544X A SG 11202112544XA SG 11202112544X A SG11202112544X A SG 11202112544XA
- Authority
- SG
- Singapore
- Prior art keywords
- cov
- sars
- reagents
- infection
- diagnosis
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
- G01N33/6857—Antibody fragments
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54326—Magnetic particles
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/165—Coronaviridae, e.g. avian infectious bronchitis virus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/12—Pulmonary diseases
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20158348 | 2020-02-19 | ||
| EP20158626.0A EP3715847A1 (en) | 2020-02-20 | 2020-02-20 | A method and reagents for the diagnosis of sars-cov-2 |
| EP20158821 | 2020-02-21 | ||
| DE202020003564 | 2020-08-20 | ||
| DE202020104982 | 2020-08-28 | ||
| PCT/EP2021/054113 WO2021165448A1 (en) | 2020-02-19 | 2021-02-19 | Methods and reagents for diagnosis of sars-cov-2 infection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202112544XA true SG11202112544XA (en) | 2021-12-30 |
Family
ID=74591943
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202112544XA SG11202112544XA (en) | 2020-02-19 | 2021-02-19 | Methods and reagents for diagnosis of sars-cov-2 infection |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20210190797A1 (en) |
| EP (2) | EP3978927A3 (en) |
| JP (1) | JP7022969B2 (en) |
| KR (1) | KR102570713B1 (en) |
| CN (1) | CN113557431A (en) |
| AU (1) | AU2021223701B2 (en) |
| BR (1) | BR102021003012A2 (en) |
| CA (1) | CA3109607C (en) |
| DE (2) | DE202021100842U1 (en) |
| ES (1) | ES2822295T1 (en) |
| MX (1) | MX2022010234A (en) |
| RU (1) | RU2021134819A (en) |
| SG (1) | SG11202112544XA (en) |
| WO (1) | WO2021165448A1 (en) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112300251B (en) * | 2020-02-24 | 2022-04-05 | 成都威斯克生物医药有限公司 | Protein and vaccine for anti SARS-CoV-2 infection |
| CN113087777B (en) * | 2020-04-17 | 2023-05-05 | 成都威斯克生物医药有限公司 | Protein for resisting SARS-CoV-2 infection and vaccine prepared by using said protein |
| US11644456B2 (en) * | 2020-04-28 | 2023-05-09 | Brandon Heeger | Rapid testing mechanism and method for respiratory viral pathogens |
| IT202000009625A1 (en) * | 2020-04-30 | 2021-10-30 | Takis S R L | SARS-COV-2 ANTIGEN CODING POLYNUCLEOTIDES AND RELATED USE IN THE MEDICAL FIELD AS VACCINES. |
| GB202006815D0 (en) * | 2020-05-07 | 2020-06-24 | Senseutics Ltd | Method |
| WO2021222988A1 (en) * | 2020-05-07 | 2021-11-11 | Griffith University | Cell entry-modulating agents and uses therefor |
| US11740240B2 (en) * | 2020-07-20 | 2023-08-29 | Bio-Rad Laboratories, Inc. | Immunoassay for SARS-CoV-2 neutralizing antibodies and materials therefor |
| CN114057846B (en) * | 2020-08-07 | 2024-04-02 | 清华大学 | Polypeptide and immunogenic conjugate for preventing novel coronavirus infection COVID-19 and application thereof |
| CN112028978B (en) * | 2020-09-07 | 2023-06-16 | 重庆医科大学 | Novel coronavirus specific CD8 + T cell epitope peptide and application thereof |
| US20220139567A1 (en) * | 2020-10-30 | 2022-05-05 | The Boeing Company | Methods for modeling infectious disease test performance as a function of specific, individual disease timelines |
| JP6976621B1 (en) * | 2021-02-04 | 2021-12-08 | 株式会社Icst | Inspection equipment, inspection kits and inspection methods |
| KR102426782B1 (en) * | 2021-04-27 | 2022-07-28 | 국민대학교산학협력단 | Diagnostic composition or Kit comprising SARS-CoV-2 RBD antigen specific antibody |
| WO2022231320A1 (en) * | 2021-04-27 | 2022-11-03 | 국민대학교산학협력단 | Antibody binding specifically to sars-cov-2 s protein or antigen-binding fragment thereof, and uses thereof |
| WO2023033363A1 (en) * | 2021-09-06 | 2023-03-09 | 국민대학교산학협력단 | Bispecific antibody specifically binding to sars-cov-2 |
| CN113046370B (en) * | 2021-05-31 | 2021-09-07 | 北京华芢生物技术有限公司 | Gene of novel coronavirus B.1.1.7 British mutant RBD and application thereof |
| WO2022253260A1 (en) * | 2021-06-01 | 2022-12-08 | 南京金斯瑞生物科技有限公司 | Detection kit for neutralizing antibody for novel coronavirus and mutant strain thereof |
| GB202110391D0 (en) | 2021-07-19 | 2021-09-01 | Tissue Click Ltd | A detection kit and methods of detection of infectious agents |
| KR102602561B1 (en) * | 2021-09-16 | 2023-11-17 | 한국공학대학교산학협력단 | Biosensor based on lateral flow analysis for 2019 novel coronavirus neutralizing antibody detection |
| CN113801963B (en) * | 2021-09-17 | 2024-03-26 | 佛山科学技术学院 | Primer probe combination, kit and method for detecting coronavirus |
| CN113929773B (en) * | 2021-10-08 | 2023-02-28 | 国际遗传工程和生物技术中心泰州区域研究中心 | anti-SARS-CoV-2 S1-RBD monoclonal antibody and its application |
| WO2023064631A1 (en) * | 2021-10-15 | 2023-04-20 | Chan Zuckerberg Biohub, Inc. | Engineering antigen binding to, and orientation on, adjuvants for enhanced humoral responses and immunofocusing |
| CN114075553B (en) * | 2021-10-30 | 2023-10-03 | 西北工业大学 | Pseudo virus particle used for evaluating activity of neutralizing antibody of novel coronavirus and serving as nucleic acid detection standard and preparation method thereof |
| CN114014940B (en) * | 2021-11-25 | 2022-11-15 | 华兰基因工程有限公司 | Preparation method of 2019-nCoV surface protein receptor binding region fusion protein |
| CN114262694B (en) * | 2021-12-06 | 2023-11-03 | 军事科学院军事医学研究院军事兽医研究所 | SARS-CoV-2 vaccine candidate strain using B type influenza virus as carrier and its construction method and application |
| CN114315990B (en) * | 2022-03-10 | 2022-05-27 | 北京康乐卫士生物技术股份有限公司 | Preparation and application of novel coronavirus specific monoclonal antibody |
| CN114774412A (en) * | 2022-03-15 | 2022-07-22 | 上海市东方医院（同济大学附属东方医院） | New coronavirus vmiRNA precursor sequence, new coronavirus vmiRNA and application |
| CN114814216B (en) * | 2022-06-30 | 2022-10-18 | 中国科学院基础医学与肿瘤研究所(筹) | Aptamer-antibody mixed sandwich method for identifying novel corona nucleocapsid protein |
| WO2024029523A1 (en) * | 2022-08-02 | 2024-02-08 | 応用酵素医学研究所株式会社 | Method for providing information for assessing evaluation items for coronavirus diseases |
| CN115951051B (en) * | 2022-10-18 | 2024-01-12 | 北京卓诚惠生生物科技股份有限公司 | Novel high-sensitivity coronavirus antigen colloidal gold detection kit and preparation method thereof |
| CN117144063B (en) * | 2023-09-15 | 2024-04-19 | 果然基因科技(山东)股份有限公司 | 12 Respiratory tract pathogen fluorescence PCR melting curve kit |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPP221098A0 (en) | 1998-03-06 | 1998-04-02 | Diatech Pty Ltd | V-like domain binding molecules |
| TW200512457A (en) * | 2003-06-10 | 2005-04-01 | Agency Science Tech & Res | Method of diagnosing SARS corona virus infection |
| CN1609617B (en) * | 2003-09-29 | 2012-02-15 | 香港中文大学 | Composition and method for diagnosing and preventing serious acute respiratory syndrome(SARS) |
| TWI303249B (en) * | 2004-01-09 | 2008-11-21 | Nat Health Research Institutes | Receptor binding polypeptides |
| CN101039955A (en) * | 2004-06-04 | 2007-09-19 | 巴斯德研究院 | Nucleic acids, polypeptides, methods of expression, and immunogenic compositions associated with sars corona virus spike protein |
| CA2568838A1 (en) * | 2004-06-04 | 2005-12-15 | Institut Pasteur | Nucleic acids, polypeptides, methods of expression, and immunogenic compositions associated with sars corona virus spike protein |
| US20060188519A1 (en) * | 2004-06-14 | 2006-08-24 | To Cheung | Peptides, antibodies, and methods for the diagnosis of SARS |
| GB0725239D0 (en) | 2007-12-24 | 2008-02-06 | Oncimmune Ltd | Calibrator for autoantibody assay |
| DE202011106093U1 (en) | 2011-09-24 | 2011-10-19 | Euroimmun Medizinische Labordiagnostika Ag | Calibration strips for an immunoblot |
| KR20150064104A (en) | 2012-09-23 | 2015-06-10 | 에라스무스 유니버시티 메디컬 센터 로테르담 | Human Betacoronavirus Lineage C and Identification of N-terminal Dipeptidyl Peptidase as Its Virus Receptor |
| CN113624977A (en) * | 2020-05-09 | 2021-11-09 | 中国科学技术大学 | Diagnostic method for SARS-CoV-2 infection |
| EP4105228A4 (en) * | 2020-05-11 | 2023-10-11 | Hengda Biomedical Technology Co., Ltd. | Sars-cov-2 antigen polypeptide, recombinant adeno-associated virus thereof, and application in preparation of vaccine |
| CN111518175B (en) * | 2020-05-11 | 2021-02-26 | 广东珩达生物医药科技有限公司 | SARS-COV-2 antigen polypeptide and its recombinant adeno-associated virus and application in preparing vaccine |
-
2021
- 2021-02-18 BR BR102021003012A patent/BR102021003012A2/en not_active Application Discontinuation
- 2021-02-19 RU RU2021134819A patent/RU2021134819A/en unknown
- 2021-02-19 AU AU2021223701A patent/AU2021223701B2/en active Active
- 2021-02-19 EP EP22152107.3A patent/EP3978927A3/en not_active Withdrawn
- 2021-02-19 KR KR1020217042841A patent/KR102570713B1/en active IP Right Grant
- 2021-02-19 WO PCT/EP2021/054113 patent/WO2021165448A1/en active Application Filing
- 2021-02-19 ES ES21158065T patent/ES2822295T1/en active Pending
- 2021-02-19 US US17/180,616 patent/US20210190797A1/en not_active Abandoned
- 2021-02-19 DE DE202021100842.3U patent/DE202021100842U1/en active Active
- 2021-02-19 JP JP2021025434A patent/JP7022969B2/en active Active
- 2021-02-19 CA CA3109607A patent/CA3109607C/en active Active
- 2021-02-19 DE DE21158065.9T patent/DE21158065T1/en active Pending
- 2021-02-19 EP EP21158065.9A patent/EP3809137A1/en active Pending
- 2021-02-19 SG SG11202112544XA patent/SG11202112544XA/en unknown
- 2021-02-19 CN CN202180001126.9A patent/CN113557431A/en active Pending
- 2021-02-19 MX MX2022010234A patent/MX2022010234A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2022010234A (en) | 2022-11-16 |
| JP7022969B2 (en) | 2022-02-21 |
| EP3978927A3 (en) | 2022-06-22 |
| WO2021165448A1 (en) | 2021-08-26 |
| US20210190797A1 (en) | 2021-06-24 |
| AU2021223701A1 (en) | 2022-01-06 |
| EP3809137A1 (en) | 2021-04-21 |
| RU2021134819A (en) | 2022-02-17 |
| BR102021003012A2 (en) | 2021-11-30 |
| DE202021100842U1 (en) | 2021-08-17 |
| CA3109607C (en) | 2023-04-04 |
| EP3978927A2 (en) | 2022-04-06 |
| AU2021223701B2 (en) | 2022-05-19 |
| KR20220006125A (en) | 2022-01-14 |
| CA3109607A1 (en) | 2021-05-20 |
| KR102570713B1 (en) | 2023-08-25 |
| JP2021167805A (en) | 2021-10-21 |
| DE21158065T1 (en) | 2021-06-10 |
| CN113557431A (en) | 2021-10-26 |
| ES2822295T1 (en) | 2021-04-30 |
| RU2021134819A3 (en) | 2022-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11202112544XA (en) | Methods and reagents for diagnosis of sars-cov-2 infection | |
| PL3869199T3 (en) | A method and reagents for the diagnosis of sars-cov-2 | |
| EP3844777A4 (en) | Medical device and method for diagnosis and treatment of disease | |
| DE112019002179A5 (en) | DEVICE AND METHOD FOR CONTAMINATION-FREE PERFORMANCE OF AN ENDOSCOPIC EXAMINATION | |
| GB202210382D0 (en) | Primer and probe sets for pathogen detection of infection in transplant patient, kit and use thereof | |
| EP4107528A4 (en) | Method and system for diagnosis and management of gastroesophageal diseases | |
| EP4138646A4 (en) | Clinical diagnosis and treatment planning system and methods of use | |
| EP4121760A4 (en) | Systems and methods for non-invasive determination of covid-19 coronavirus infection | |
| IL285788A (en) | System and method for enhanced imaging of biological tissue | |
| EP4244785A4 (en) | Computationally-efficient load planning systems and methods of diagnostic laboratories | |
| EP4117820A4 (en) | Methods and systems for physical expansion and imaging of biological samples | |
| EP3941359C0 (en) | Swab for biological sampling | |
| GB202006144D0 (en) | Method of diagnosing a biological entity, and diagnostic device | |
| EP3811989A4 (en) | Blood purification device and method for estimating nutritional state of patient using blood purification device | |
| EP3902397A4 (en) | Device, system, and method for rapid fixation and embedding of biological specimens | |
| GB202012146D0 (en) | Test for risk of covid-19 infection | |
| EP4004227A4 (en) | Method for antibiotic susceptibility testing of blood samples | |
| IT201700085439A1 (en) | METHOD OF IMMOBILIZATION OF BIOLOGICAL SAMPLES FOR ANALYTICAL AND DIAGNOSTIC PURPOSE | |
| GB202006742D0 (en) | Device, system and method for diagnosis of specific infections | |
| CA214494S (en) | Apparatus for medical or laboratory diagnosis | |
| CA214495S (en) | Apparatus for medical or laboratory diagnosis | |
| CA199078S (en) | Apparatus for medical or laboratory diagnosis | |
| CA199079S (en) | Apparatus for medical or laboratory diagnosis | |
| AU2020903132A0 (en) | Methods of detecting and/or diagnosing brain cancer | |
| GB202213287D0 (en) | Methods of diagnosis and treatment |